Empresa Recursion Pharmaceuticals, Inc.
Acciones
RXRX
US75629V1044
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
8,33 USD | +6,52 % | +8,18 % | -15,52 % |
Resumen de negocios
Número de empleados: 500
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Drug Discovery
100,0
%
| 40 | 100,0 % | 45 | 100,0 % | +11,88 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 40 | 100,0 % | 45 | 100,0 % | +11,88 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 41 | 05/11/13 | |
Blake Borgeson
FOU | Founder | 42 | 05/11/13 |
Dean Li
FOU | Founder | 62 | 05/11/13 |
Tina Larson
PSD | President | 49 | 01/07/18 |
Michael Secora
DFI | Director of Finance/CFO | 41 | 01/03/20 |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | 16/08/21 | |
Benjamin Mabey
CTO | Chief Tech/Sci/R&D Officer | 41 | 01/03/17 |
Laura Schaevitz
CTO | Chief Tech/Sci/R&D Officer | - | - |
David Mauro
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/06/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20/03/20 |
Chairman | 60 | 01/04/20 | |
Dean Li
FOU | Founder | 62 | 05/11/13 |
Blake Borgeson
FOU | Founder | 42 | 05/11/13 |
Zachary Bogue
BRD | Director/Board Member | 48 | 01/08/18 |
Zavain Dar
BRD | Director/Board Member | 35 | 01/09/16 |
Founder | 41 | 05/11/13 | |
Director/Board Member | 47 | 01/04/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 10 | 7 509 871 | 0 | 0 | 91,44 % |
Acción B | 1 | 230 107 332 | 217 267 089 ( 94,42 %) | 0 |
Información de la empresa
Recursion Pharmaceuticals, Inc.
41 South Rio Grande Street
84101, Salt Lake City
+
http://www.recursion.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-20,69 % | 1861,03 M | |
-3,46 % | 102 mil M | |
+1,41 % | 96,09 mil M | |
+2,13 % | 22,28 mil M | |
-15,84 % | 21,4 mil M | |
-10,21 % | 18,14 mil M | |
-39,98 % | 17,02 mil M | |
-14,65 % | 16,09 mil M | |
+4,39 % | 13,83 mil M | |
+31,35 % | 11,97 mil M |
- Bolsa de valores
- Acciones
- Acción RXRX
- Empresa Recursion Pharmaceuticals, Inc.